Clinical Efficacy and Safety Assessment of Oxaliplatin and Fluorouraciland, Leucovorin [modified FOLFOX6] in Combination with High-dose Bevacizumab as Second-line Therapy in Patients with Advanced or Recurrent Colorectal Cancer after Failure to Irinotecan. Multicenter Clinical Study.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2625142
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: High-dose Bevacizumab + sLV5FU2 Bevacizumab 10mg/kg (d.i.v) L-OHP 85 mg/m2 (d.i.v) l-LV 200mg/m2 (d.i.v) 5-FU 400mg/m2 (b.i.v) 5-FU 2400mg/m2 (c.i.v) Every 2weeks
Primary outcome(s): Progression free survival [PFS]
Study Design: Single arm Non-randomized
创建时间：
2013-01-15
